Desmopressin acetate NDC 71288-441

NDC codes

FDA NDC Directory

Product NDC (as listed)71288-441Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71288-0441Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
71288-441-10	71288044110	1 VIAL in 1 CARTON (71288-441-10) / 10 mL in 1 VIALMarketed from Feb 13, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Desmopressin acetate
Generic name (nonproprietary): desmopressin acetate
Active ingredients: Desmopressin acetate — 4 ug/mL
Dosage form: Injection
Route: Intravenous, Subcutaneous
Labeler: Meitheal Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 074888
Marketing start: Feb 13, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Increased Coagulation Factor VIII Activity (Physiologic effect)Increased Coagulation Factor VIII Concentration (Physiologic effect)Vasopressins (Chemical structure)
Identifiers: Product ID 71288-441_4cd11e26-c85f-447c-8a97-56215fdf7b1fSPL ID 4cd11e26-c85f-447c-8a97-56215fdf7b1fSPL set ID 2a2a6eba-c5bf-4ee4-bb18-c992ae59dce5RxCUI 849501, 1723232UNII XB13HYU18U
Pharmacologic class: Factor VIII Activator; Vasopressin Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N471288044110 followed by a unit qualifier and the quantity

Package 71288-0441-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 23, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Desmopressin Acetate Injection is a vasopressin analog used for: Central Diabetes Insipidus - as antidiuretic replacement therapy in the management of central (cranial) diabetes insipidus and for the management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitary region. ( 1.1 ) Hemophilia A- for patients with factor VIII coagulant activity levels greater than 5% to maintain hemostasis during surgical procedures and postoperatively or reduce bleeding with episodes of spontaneous or traumatic injuries such as hemarthroses, intramuscular hematomas, or mucosal bleeding. ( 1.2 ) von Willebrand’s disease (Type I) - for patients with mild to moderate disease w…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 074888

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 074888
Product	Strength	Form · route	Labeler	Product NDC
Desmopressin acetate	Desmopressin acetate 4 ug/mL	InjectionIntravenous, Subcutaneous	Meitheal Pharmaceuticals Inc.	71288-440